First-Line Blasenkarzinom-Studie der AUO

Author：  

Publisher： Springer Publishing Company

ISSN： 0947-8965

Source： Der Onkologe, Vol.13, Iss.6, 2007-06, pp. : 546-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

AUO-Studie beim hormonrefraktären Prostatakarzinom

By  

Der Onkologe, Vol. 13, Iss. 7, 2007-07 ,pp. : 644-644

Springer Publishing Company

Access to resources Recommend Favorite

AUO-Studie zur operativen Therapie des Harnblasenkarzinoms

By  

Der Onkologe, Vol. 13, Iss. 9, 2007-09 ,pp. : 860-861

Springer Publishing Company

Access to resources Recommend Favorite

Aktivierte Prostatakarzinom-Studien der AUO in 2007

By Rexer H.  

Der Onkologe, Vol. 13, Iss. 8, 2007-08 ,pp. : 740-742

Springer Publishing Company

Access to resources Recommend Favorite

Onapristone, a Progesterone Receptor Antagonist, as First-line Therapy in Primary Breast Cancer

By Robertson J.F.R.   Willsher P.C.   Winterbottom L.   Blamey R.W.   Thorpe S.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 214-218

Elsevier

Access to resources Recommend Favorite

Erlotinib in the first-line treatment of non-small-cell lung cancer

By D'Arcangelo Manolo   Cappuzzo Federico  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 523-533

Informa Healthcare

Access to resources Recommend Favorite